FOURTH EXTENSION - GRANTED
granted
on 21 Oct 2024
Last Applicant/ Owned by
329 Oyster Point Blvd.
South San Francisco
CA
94080
Serial Number
97141904 filed on 24th Nov 2021
Registration Number
N/A
Correspondent Address
R. Gwen Peterson
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
A
Biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
Classification Information
Class [005]
Pharmaceutical Products
Biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97141904
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 1286145
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Oct 2024 | SOU EXTENSION 4 GRANTED |
| 21st Oct 2024 | SOU EXTENSION 4 FILED |
| 21st Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 19th Apr 2024 | CORRECTED NOA E-MAILED |
| 18th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Apr 2024 | SOU EXTENSION 3 GRANTED |
| 18th Apr 2024 | DIVISIONAL PROCESSING COMPLETE |
| 21st Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 01st Mar 2024 | TEAS REQUEST TO DIVIDE RECEIVED |